CompletedPhase 2NCT00787761
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Northside Hospital, Inc.
- Principal Investigator
- Asad Bashey, MD, PhD, FNP-BCBlood and Marrow Transplant Group of Georgia
- Intervention
- anti-thymocyte globulin(biological)
- Enrollment
- 24 enrolled
- Eligibility
- 75 years · All sexes
- Timeline
- 2007 – 2012
Study locations (1)
- Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia, United States
Collaborators
Blood and Marrow Transplant Group of Georgia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00787761 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.